02348.HK
Dawnrays Pharmaceutical (Holdings) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.92
−1.60%Margins
Gross margin
47.8%
EBITDA margin
31.7%
EBIT margin
20.7%
Net margin
20.3%
FCF margin
26.2%
6.7%
Return on equity
5.8%
Return on assets
6.9%
Return on invested capital
0.28x
Asset turnover
HKD 443.3M
Cash from operations
HKD 1.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026